The Discovery of Anthranilic Acid-based MMP Inhibitors. Part 3: Incorporation of Basic Amines
Overview
Authors
Affiliations
Anthranilic acid derivatives bearing basic amines were prepared and evaluated in vitro and in vivo as inhibitors of MMP-1, MMP-9, MMP-13, and TACE. Piperazine 4u has been identified as a potent, selective, orally active inhibitor of MMP-9 and MMP-13.
Haiba N, Khalil H, Bergas A, Abu-Serie M, Khattab S, Teleb M ACS Omega. 2022; 7(24):21131-21144.
PMID: 35755386 PMC: 9219090. DOI: 10.1021/acsomega.2c01949.
Sanapalli B, Yele V, Jupudi S, Karri V RSC Adv. 2022; 11(43):26820-26831.
PMID: 35480006 PMC: 9037691. DOI: 10.1039/d1ra03891e.
Gonzalez-Alvarez H, Bravo-Jimenez A, Martinez-Arellanes M, Gamboa-Osorio G, Chavez-Gutierrez E, Gonzalez-Hernandez L Pharmaceuticals (Basel). 2021; 14(9).
PMID: 34577613 PMC: 8466046. DOI: 10.3390/ph14090914.
Itoh S, Hamada E, Kamoshida G, Takeshita K, Oku T, Tsuji T Infect Immun. 2010; 78(7):3298-305.
PMID: 20479083 PMC: 2897379. DOI: 10.1128/IAI.00178-10.
Saito Y, Sekine W, Sano R, Komatsu S, Mizuno H, Katabami K Clin Exp Metastasis. 2010; 27(4):197-205.
PMID: 20352300 DOI: 10.1007/s10585-010-9314-3.